Bath & Body Works, Inc. $BBWI Shares Purchased by Intech Investment Management LLC

Intech Investment Management LLC increased its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWIFree Report) by 462.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 108,766 shares of the company’s stock after purchasing an additional 89,432 shares during the quarter. Intech Investment Management LLC’s holdings in Bath & Body Works were worth $2,184,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Gabelli Funds LLC boosted its holdings in Bath & Body Works by 1.2% in the 3rd quarter. Gabelli Funds LLC now owns 47,536 shares of the company’s stock worth $1,225,000 after acquiring an additional 542 shares during the period. State of Wyoming boosted its holdings in Bath & Body Works by 6.2% in the 2nd quarter. State of Wyoming now owns 11,294 shares of the company’s stock worth $338,000 after acquiring an additional 661 shares during the period. Vident Advisory LLC boosted its holdings in Bath & Body Works by 2.8% in the 2nd quarter. Vident Advisory LLC now owns 25,229 shares of the company’s stock worth $756,000 after acquiring an additional 692 shares during the period. Synovus Financial Corp boosted its holdings in Bath & Body Works by 1.4% in the 3rd quarter. Synovus Financial Corp now owns 56,210 shares of the company’s stock worth $1,448,000 after acquiring an additional 764 shares during the period. Finally, Geneos Wealth Management Inc. boosted its holdings in Bath & Body Works by 217.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after acquiring an additional 801 shares during the period. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Wall Street Analyst Weigh In

BBWI has been the subject of a number of analyst reports. Raymond James Financial restated a “market perform” rating on shares of Bath & Body Works in a report on Wednesday, May 27th. Weiss Ratings cut Bath & Body Works from a “hold (c-)” rating to a “sell (d+)” rating in a report on Tuesday. UBS Group decreased their price target on Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, May 20th. Piper Sandler initiated coverage on Bath & Body Works in a report on Friday, May 15th. They issued a “neutral” rating and a $20.00 price target for the company. Finally, The Goldman Sachs Group decreased their price target on Bath & Body Works from $26.00 to $23.00 and set a “neutral” rating for the company in a report on Thursday, May 28th. Three analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Bath & Body Works presently has a consensus rating of “Hold” and an average target price of $21.93.

Check Out Our Latest Report on BBWI

Bath & Body Works Trading Down 3.6%

Bath & Body Works stock opened at $18.05 on Thursday. The stock has a market cap of $3.64 billion, a P/E ratio of 5.07, a price-to-earnings-growth ratio of 1.86 and a beta of 1.42. The stock has a 50 day moving average of $18.59 and a 200-day moving average of $20.13. Bath & Body Works, Inc. has a 52 week low of $14.27 and a 52 week high of $33.96.

Bath & Body Works (NYSE:BBWIGet Free Report) last released its earnings results on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.29 by $0.03. The company had revenue of $1.38 billion during the quarter, compared to analysts’ expectations of $1.36 billion. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The business’s revenue was down 3.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.49 EPS. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, equities analysts predict that Bath & Body Works, Inc. will post 2.61 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 19th. Stockholders of record on Friday, June 5th will be paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 4.4%. The ex-dividend date is Friday, June 5th. Bath & Body Works’s dividend payout ratio is 22.47%.

Bath & Body Works Profile

(Free Report)

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

See Also

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIFree Report).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.